Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119155032 | 11915503 | 2 | F | 201506 | 20160825 | 20160114 | 20160831 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093412 | BRISTOL MYERS SQUIBB | 78.20 | YR | M | Y | 112.40000 | KG | 20160831 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119155032 | 11915503 | 1 | PS | APIXABAN | APIXABAN | 1 | Oral | 5 MG, QD | Y | 202155 | 5 | MG | FILM-COATED TABLET | QD | |||||
| 119155032 | 11915503 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, QD | Y | 0 | 325 | MG | QD | ||||||
| 119155032 | 11915503 | 3 | SS | DOXYCYCLINE HYCLATE. | DOXYCYCLINE HYCLATE | 1 | Oral | 100 MG, QD | Y | 0 | 100 | MG | QD | ||||||
| 119155032 | 11915503 | 4 | SS | TYLENOL PM | ACETAMINOPHENDIPHENHYDRAMINE | 1 | Oral | 1 TAB, PRN | Y | 0 | 1 | DF | TABLET | ||||||
| 119155032 | 11915503 | 5 | SS | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | Oral | 3.75 MG, QD | Y | 0 | 3.75 | MG | QD | ||||||
| 119155032 | 11915503 | 6 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | 0 | ||||||||||
| 119155032 | 11915503 | 7 | C | DILTIAZEM. | DILTIAZEM | 1 | Unknown | UNK | 0 | ||||||||||
| 119155032 | 11915503 | 8 | C | COENZYME Q10 | UBIDECARENONE | 1 | Unknown | UNK | 0 | ||||||||||
| 119155032 | 11915503 | 9 | C | CORTISPORIN /00271401/ | 2 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119155032 | 11915503 | 1 | Cerebrovascular accident prophylaxis |
| 119155032 | 11915503 | 2 | Cerebrovascular accident prophylaxis |
| 119155032 | 11915503 | 3 | Rosacea |
| 119155032 | 11915503 | 4 | Sleep disorder |
| 119155032 | 11915503 | 5 | Hyperlipidaemia |
| 119155032 | 11915503 | 6 | Product used for unknown indication |
| 119155032 | 11915503 | 7 | Product used for unknown indication |
| 119155032 | 11915503 | 8 | Product used for unknown indication |
| 119155032 | 11915503 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119155032 | 11915503 | OT |
| 119155032 | 11915503 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119155032 | 11915503 | Haemorrhagic anaemia | |
| 119155032 | 11915503 | Lower gastrointestinal haemorrhage | |
| 119155032 | 11915503 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119155032 | 11915503 | 1 | 201506 | 0 | ||
| 119155032 | 11915503 | 2 | 201506 | 0 | ||
| 119155032 | 11915503 | 3 | 2011 | 0 | ||
| 119155032 | 11915503 | 4 | 2011 | 0 | ||
| 119155032 | 11915503 | 5 | 201211 | 0 | ||
| 119155032 | 11915503 | 6 | 2011 | 0 | ||
| 119155032 | 11915503 | 7 | 2011 | 0 | ||
| 119155032 | 11915503 | 8 | 2011 | 0 | ||
| 119155032 | 11915503 | 9 | 201506 | 0 |